Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F9S38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,284
Award facts
- Contract value 100% obligated
- $13,283.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,283.72 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen injectors. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with a completion date of December 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to military and veteran healthcare systems. SKYRIZI is a biologics medication used to treat autoimmune and inflammatory conditions, and this order supports the DLA's Medical Supply Chain mission to ensure adequate pharmaceutical inventories for Defense Health Agency operations and other federal healthcare entities. AmerisourceBergen's extensive experience fulfilling federal pharmaceutical requirements through competitive contracting, combined with its large umbrella IDC vehicle, positions it as a primary vendor for the DLA's global pharmaceutical distribution network serving military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9S38?
SPE2DR26F9S38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9S38 worth?
The government has obligated $13,284 on SPE2DR26F9S38.
Is contract SPE2DR26F9S38 an order under another contract?
Yes. SPE2DR26F9S38 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9S38 competed?
The extent of competition for SPE2DR26F9S38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award